"I have made all the appropriate decisions – soon our compatriot will formally be a Polish citizen," he said in a video recording posted on X on Thursday. Tusk further reported that he met with Ambros ...
Savara Inc. (the "Company") (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, ...
Zero Trust isn't magic. It's a specific set of architectural components working together—policy engine, identity fabric, ...
-- Company Plans to Submit the MOLBREEVI Marketing Authorization Applications (MAAs) for Autoimmune PAP to the European Medicines Agency (EMA) and the Medicines and Healthcare Products Regulatory ...
Asianet Newsable on MSN
SVRA stock rises after hours as FDA grants priority review for lung disorder therapy
The company is seeking approval for Molbreevi to treat patients with Autoimmune Pulmonary Alveolar Proteinosis (autoimmune PAP).
AFPs collaborate with self-funded health plans to manage specialty medication costs, often excluding coverage and requiring alternative sourcing. They impact market access strategies, patient services ...
You can still get a Pap smear while on your period, but heavy bleeding might affect test accuracy. Light bleeding or spotting usually won't affect Pap smear results. Healthcare providers generally ...
The Health and Human Services Department endorsed on Monday the use of self-administered tests for the virus that causes cervical cancer, to increase access to screening. Doctors typically swab a ...
-- The BLA was Resubmitted with FUJIFILM Biotechnologies (Fujifilm) as the Drug Substance Manufacturer and Priority Review was Requested -- MOLBREEVI was granted Fast Track and Breakthrough Therapy ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果